A Porcine Parvovirus Subunit Vaccine
A subunit vaccine, parvovirus technology, applied in the direction of viruses, vaccines, antiviral agents, etc., can solve the problems of cumbersome antigen process, immunosuppressive side effects, allergies, etc., to ensure immune effect, improve antibody level, and good safety. Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0015] Embodiment 1: Screening of porcine parvovirus (PPV) VP2 gene
[0016] In 2010, symptoms of porcine parvovirus disease appeared in many farms in Shandong Province, and the individual pigs with the disease had been injected with the existing parvovirus vaccine before, and it was speculated that the infected virus had mutated; Screening; the porcine parvovirus PPV1 was finally screened out.
[0017] In order to verify the antigenicity of the screened virus, five virus strains from different sources, including the screened PPV1 strain, were used as antigens to prepare vaccines. After immunizing SPF pigs, the screened virus liquid was used to challenge the virus. The results showed that Compared with other porcine parvovirus vaccines, the vaccine prepared by itself has a better immune effect (p<0.05), so it is confirmed that it has a genetic variation.
[0018] According to the antigenic characteristics and amino acid sequence of porcine parvovirus VP2 protein, a pair of pr...
Embodiment 2
[0022] Example 2: Preparation of recombinant porcine parvovirus VP2 protein
[0023] The method comprises the following steps: a. constructing an expression vector; b. constructing an expression strain; c. inducing, extracting and purifying the recombinant VP2 protein. The details are as follows: The positive cloned plasmid pMD18-T-VP2 and the expression vector pPICZα vector were digested with KpnI and NotI respectively, and after 1.2% agarose gel electrophoresis, they were recovered with a DNA gel recovery kit, and about 1.7 kb were obtained respectively. and 3.3kb fragments were oriented at 16°C to construct pPICZα-VP2 expression vector, after the correct identification by restriction enzyme digestion; after the plasmid was linearized, it was electrotransformed into Pichia pastoris competent cells to construct Pichia pastoris expression strain X33-VP2, The genome of the expressed strain X33-VP2 was extracted and identified correctly by PCR using primers primer 1 and primer 2...
Embodiment 3
[0024] Embodiment 3: the preparation of vaccine
[0025] The Pichia pastoris expression strain X33-VP2 strain producing porcine parvovirus VP2 protein was deposited in China Center for Type Culture Collection with the preservation number CCTCC M 2016098.
[0026] 1. Preparation of bacterial solution for making seedlings Inoculate the X33-VP2 bacterial strain in YPD liquid medium containing bleomycin, and culture with shaking at 30°C for 16-18 hours. Then streak and inoculate in YPD solid medium with bleomycin, select 2 to 3 typical colonies and mix them in a small amount of YPD liquid medium, place them in a shaker at 30°C for 18 hours, and quantitatively pack them. After inspection, it is used as a first-class seed. Take the primary seeds and inoculate them in BMGY liquid medium, culture them with shaking at 30°C for 16-18 hours, and store them at 2-8°C after microscopic examination, as the secondary seeds.
[0027] 2. Preparation of protein for seedling production. Add BMG...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com